Literature DB >> 7678777

Heterogeneity of mucin gene expression in normal and neoplastic tissues.

S B Ho1, G A Niehans, C Lyftogt, P S Yan, D L Cherwitz, E T Gum, R Dahiya, Y S Kim.   

Abstract

To determine the relative expression of distinct mucin genes in normal and neoplastic tissue, antibodies and cDNA probes that recognize the core tandem repeat sequences of membrane-bound (MUC1) and secreted (MUC2 and MUC3) mucins were used for immunohistochemical and RNA Northern and slot-blot analysis. MUC1 mRNA was detected in all epithelial tissues tested. MUC1 core peptide, recognized by monoclonal antibodies 139H2 and DF3, was highly expressed on apical membranes of bronchus, breast, salivary gland, pancreas, prostate, and uterus, and was sparsely expressed in gastric surface cells, gallbladder, small intestine, and colonic epithelium. In contrast, MUC2 and MUC3 gene expression was primarily restricted to the intestinal tract. MUC2 mRNA was highly expressed in normal jejunum, ileum, and colon, compared with very low levels in normal bronchus and gallbladder. MUC3 mRNA was highly expressed in normal jejunum, ileum, colon, and gallbladder. Immunohistochemical studies using antibodies against synthetic MUC2 (anti-MRP) and MUC3 (anti-M3P) peptides indicate that MUC2- and MUC3-producing cells in the gastrointestinal tract are distinct. Goblet cells of the small intestine and colon reacted strongly with anti-MRP, whereas M3P reactivity was restricted to columnar cells of small intestinal villi, surface colonic epithelium, and gallbladder. Mucin protein epitopes and mRNA levels were frequently altered in adenocarcinomas compared to corresponding normal tissues. Alterations included increased expression, aberrant expression, and, less frequently, loss of expression. Increased MUC1 immunoreactivity was observed in most adenocarcinomas of the breast, lung, stomach, pancreas, prostate, and ovary. In addition, with the exception of prostate cancer, focal aberrant expression of MUC2 and MUC3 epitopes was frequently observed. Increased MUC1, MUC2, and MUC3 epitopes were present in colon adenocarcinomas of all histological subtypes, with the greatest increase of MUC2 epitopes observed in colloid (mucinous) colon cancers. MUC2 or MUC3 mRNA levels were increased in colloid colon cancer compared with normal colon, however in well- and moderately well-differentiated colon cancers MUC1, 2 and 3 mRNA levels were decreased. Compared with corresponding normal tissue, MUC1 mRNA levels were increased in breast cancer and well-differentiated lung cancers, and MUC3 mRNA was increased in gastric adenocarcinomas. Normal stomach lacked both MUC2 and MUC3 immunoreactivity and mRNA, however, MUC2 and MUC3 proteins and mRNA were highly expressed in gastric intestinal metaplasia. In conclusion, mucin genes are independently regulated and their expression is organ- and cell type-specific. Furthermore, neoplastic transformation is associated with dys-regulated expression of both membrane-bound and secreted mucin core protein epitopes and may be due to altered mucin mRNA levels and/or altered mucin glycosylation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7678777

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  169 in total

1.  Complete sequence of the human mucin MUC4: a putative cell membrane-associated mucin.

Authors:  N Moniaux; S Nollet; N Porchet; P Degand; A Laine; J P Aubert
Journal:  Biochem J       Date:  1999-03-01       Impact factor: 3.857

2.  Pre-existing histological type and developmental mechanism of mucinous noncystic carcinoma of pancreas.

Authors:  K Suda; B Nobukawa; S Yamasaki; F Suzuki; H Shimizu; M Takase
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

Review 3.  L-BLP25 as a peptide vaccine therapy in non-small cell lung cancer: a review.

Authors:  Wenjie Xia; Jie Wang; Youtao Xu; Feng Jiang; Lin Xu
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

Review 4.  Lung cancer vaccines.

Authors:  Ronan J Kelly; Giuseppe Giaccone
Journal:  Cancer J       Date:  2011 Sep-Oct       Impact factor: 3.360

5.  Periodontal bone loss and risk of epithelial ovarian cancer.

Authors:  Ana Babic; Elizabeth M Poole; Kathryn L Terry; Daniel W Cramer; Ricardo P Teles; Shelley S Tworoger
Journal:  Cancer Causes Control       Date:  2015-04-03       Impact factor: 2.506

6.  The adherent gastric mucous layer is composed of alternating layers of MUC5AC and MUC6 mucin proteins.

Authors:  Samuel B Ho; Kenji Takamura; Ruth Anway; Laurie L Shekels; Neil W Toribara; Hiroyoshi Ota
Journal:  Dig Dis Sci       Date:  2004-10       Impact factor: 3.199

Review 7.  Giant intrahepatic biliary cystadenoma in a male: a case report, immunohistopathological analysis, and review of the literature.

Authors:  Shinsuke Kazama; Takeyuki Hiramatsu; Shigeru Kuriyama; Ken Kuriki; Ryo Kobayashi; Naoki Takabayashi; Kenichi Furukawa; Masami Kosukegawa; Hitoshi Nakajima; Kousuke Hara
Journal:  Dig Dis Sci       Date:  2005-07       Impact factor: 3.199

Review 8.  Immune therapies.

Authors:  Rao H Prabhala; Nikhil C Munshi
Journal:  Hematol Oncol Clin North Am       Date:  2007-12       Impact factor: 3.722

9.  Biosynthesis of rat MUC2 in colon and its analogy with human MUC2.

Authors:  K M Tytgat; F J Bovelander; F J Opdam; A W Einerhand; H A Büller; J Dekker
Journal:  Biochem J       Date:  1995-07-01       Impact factor: 3.857

10.  Mucin gene expression in human embryonic and fetal intestine.

Authors:  M P Buisine; L Devisme; T C Savidge; C Gespach; B Gosselin; N Porchet; J P Aubert
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.